You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 263 No. 20, May 23, 1990 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Vitamins During Pregnancy and Neural Tube Defects

James L. Mills, MD, MS
National Institute of Child Health and Human Development Bethesda, Md

George G. Rhoads, MD, MPH
University of Medicine and Dentistry of New Jersey Newark

Joe Leigh Simpson, MD
University of Tennessee Memphis

George C. Cunningham, MD
California Public Health Foundation Berkeley

JAMA. 1990;263(20):2747-2748.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

In their article entitled "Multivitamin/Folic Acid Supplementation in Early Pregnancy Reduces the Prevalence of Neural Tube Defects," Milunsky and coauthors1 suggest that recall bias or undercounting vitamin use in early pregnancy could have resulted in our study's2 finding that vitamin and folate supplement use was not associated with a decreased risk for neural tube defects.

We do not consider recall bias a problem in our study, however, because Formula more than half the women who reported supplement use were able to locate the bottle and read us the ingredients, good evidence that the data are accurately reported. Milunsky et al state that most of their subjects did not know their pregnancy outcomes at the time of their interviews. However, it would be important to know how many women, especially those with neural tube defects, knew the results of their maternal serum {alpha}-fetoprotein screening tests before they were . . . [Full Text PDF of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1990 American Medical Association. All Rights Reserved.